David E. Fisher MD, PhDLancer Professorship of Dermatology, Harvard Medical School; Chair, Department of Dermatology, Massachusetts General Hospital; Director, Melanoma Program, Mass General Cancer Center, Boston, Massachusetts
David E. Fisher, MD, PhD, is Chair of the Massachusetts General Hospital Department of Dermatology. He also serves as Director of Mass General’s Cutaneous Biology Research Center, Director of the Melanoma Center, and Chair of the MGH Executive Committee on Research. A professor of dermatology and of pediatrics at Harvard Medical School, Dr. Fisher came to Mass General from the Dana-Farber Cancer Institute, where he previously directed the melanoma program. Dr. Fisher’s research has focused on understanding the molecular and genetic events which underlie formation of melanoma as well as skin pigmentation. As a clinician, he has worked to translate these understandings into advances in diagnosis, treatment and prevention of human diseases related to the skin and associated disorders.
Dr. Fisher has a financial interest in Soltego, Inc., a company developing SIK inhibitors for topical skin darkening treatments that might be used for a broad set of human applications. Dr. Fisher's interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict-of-interest policies. He also serves as a consultant to Tasca, Torqur, and Biocoz.